Prevention of Ventilator-Associated Pneumonia with Inhaled Amikacin

Hamidi, Arzo PharmD, BCCCP

Clinical Pharmacy Specialist, Adult Critical Care, Rush University Medical Center, Chicago

Critical Care Alert 31(10):p 76-78, January 2024.

SYNOPSIS: A short course of inhaled amikacin at therapeutic doses prevented the occurrence of ventilator-associated pneumonia without changes to duration of mechanical ventilation, length of stay, or mortality.

SOURCE: Ehrmann S, Barbier F, Demiselle J, et al. Inhaled amikacin to prevent ventilator-associated pneumonia. N Engl J Med 2023; Oct 25. doi: 10.1056/NEJMoa2310307. [Online ahead of print].